Jorge J. Ramirez

Vice President, H.I.G. BioHealth Partners

Jorge Ramirez is a Vice President at H.I.G. BioHealth Partners and focuses on development stage and growth investments in the healthcare sector.

Previously, Jorge was with ProQuest Investments, a healthcare focused private equity firm. During his eight years with ProQuest, the firm raised and fully invested two funds totaling $625 million. He represented ProQuest as an observer or board member in several successful companies including: Eagle Pharmaceuticals (NASDAQ: EGRX); Mevion Medical Systems; Revision Optics; Orthocon (acquired by AbyRx); and MethylGene (now, Mirati Pharmaceutics: NASDAQ: MRTX).

Jorge has also held operating roles in healthcare companies. He was the General Manager of Neurology Products at Cyberkinetics Neurotechnology Systems. He led the regulatory and clinical development teams for an epilepsy monitoring device and had P&L responsibility for Cyberkinetics’ research products. Previously, Jorge was a management consultant at Monitor Company focusing on commercialization strategies and M&A engagements in the healthcare and manufacturing industries.

Jorge earned degrees in Neuroscience and Spanish literature from Amherst College, where he graduated magna cum laude. He earned an M.B.A. from Harvard Business School, where he was a Pfizer Scholar and Social Enterprise Fellow.